RGT 0.00% 30.0¢ argent biopharma limited

Ann: March Quarterly Activity and Cashflow Report, page-12

  1. 233 Posts.
    lightbulb Created with Sketch. 131
    The kings of bluff can’t hide behind no revenue and significant costs. This company is in real trouble IMO.

    best outcome is probably more smoke and mirrors to get SP up and fire sale exit to save face. A capital raise might be difficult in the crowded space and more dilution will put further downward pressure on SP. Seems all their deals have virtually no credibility or follow through with revenue as promised.

    I expect this to tank badly unfortunately.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $13.58M
Open High Low Value Volume
30.0¢ 31.0¢ 30.0¢ $2.567K 8.41K

Buyers (Bids)

No. Vol. Price($)
2 47481 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 8026 2
View Market Depth
Last trade - 15.53pm 21/06/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.